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Abstract 
 
Morbidly adherent placenta with spontaneous rupture of membrane at extreme prematurity poses poor pregnancy 
outcome. Various issues on different management modalities still remain perplexed and individual consideration is 
vital. Two cases of morbidly adherent placenta with symptomatic per vaginal bleeding and spontaneous rupture of 
membrane at severe prematurity were reviewed and discussed. We found that, active intervention by termination of 
pregnancy and methotrexate therapy at early gestation can prevent the need of hysterectomy following major 
obstetrics haemorrhage.  
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Introduction 
 
Morbidly adherent placenta namely placenta 
accreta is a nightmare to any obstetricians. 
Although the incidence of placenta accreta varies 
with the average incidence of approximately 1 in 
7000 (1), it is associated with major obstetric 
hemorrhage requiring massive transfusion, 
Caesarean hysterectomy and to the extreme of 
maternal mortality. Ureteric and bladder injury 
may complicate, especially in torrential bleeding, 
where life saving procedure is the top precedence 
(2). 
 
Risk of placenta accreta increases with the 
number of previous Caesarean scars, being 
approximately 25% with one scar, and up to 67% 
with four or more prior Caesarean section scar 
(3).  Myomectomy, uterine curettage and 
infection are possible risk factors other than 
placenta praevia itself, contributing to 10% of all 
cases. It is more likely if the placenta praevia is 
located anteriorly with previous Caesarean scars. 
It poses a major challenge in the antenatal 
diagnosis, especially when the investigations are 
inconclusive and largely depends on the clinical 
suspicion. Ultrasonography and magnetic 
resonance imaging (MRI) would be the adjunct 
tools in highly suspected morbidly adherence 
placenta (4). Loss of sonolucency at the placental 
bed with poor demarcation of myometrium 
overlying the placenta and presence of irregular 
lacunae are the suggestive features. Doppler 
ultrasonography reveals increased vascularity of 
the bladder and uterine interface (5,6,7). 
 
Case report 
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Uterine conservation by leaving the placenta in-
situ, curettage and/or oversewing of the placenta 
bed has shown to be effective to retain 
fertility(7). Nevertheless, leaving placenta in-situ 
is also associated with the risk of infection and 
overwhelming sepsis, bleeding requiring blood 
transfusion and to the extent of relaparotomy for 
sequential hysterectomy. Stringent monitoring 
and follow up is required and largely requires 
patients’ compliance and acceptability. To date, 
there is no general consensus on the guidelines 
for monitoring such cases.   
 
Could this nightmare be prevented or at least be 
minimised? Termination of pregnancy solely 
based on clinical suspicions of morbidly 
adherence placenta is definitely not ethically 
acceptable. Whether this could be considered on 
the grounds of prevention of maternal morbidity 
and mortality is another contentious issue since 
there is a scarcity of reported cases.  
 
 
Case report 1 
 
A 28-year-old, in her second pregnancy at 21 
weeks period of amenorrhoea, with one previous 
Caesarean section presented with per vaginal 
bleeding.The pregnancy was dated at 12 weeks 
gestation, progressed well till 16 weeks when she 
had recurrent per vaginal bleeding. She first 
presented with minimal per vaginal bleeding and 
was diagnosed as threatened miscarriage and was 
managed conservatively. Unfortunately, she was 
readmitted three days later for another episode of 
bleeding, requiring one unit of packed cell 
transfusion as her haemoglobin dropped to 8 
g/dL with symptomatic anaemia. At 17 weeks 
gestation, she had another episode of excessive 
per vaginal bleeding again with haemoglobin of 
6.2 g/dL, requiring four units of blood 
transfusion. An obstetric scan revealed fetal 
parameters corresponding to her dates with low 
lying placenta.  Even with this major consecutive 
haemorrhage, no definitive plan had been 
discussed. 
 
Following this she remained asymptomatic for 
one month, until at 21 weeks pregnancy where at 
that point of time, she presented with vaginal 
spotting and leaking liquor. She was not pale, 
haemodynamically stable and afebrile. No 
evidence of abruptio placenta, and uterus 
corresponded to the dates. Scan revealed a viable 
singleton fetus in breech presentation at 
parameters of 21 to 22 weeks pregnancy with 
oligohydramnion. Placenta was low lying, 
covering the cervix. Lacunae signs were present, 
with loss of delineation between placenta tissue 
and myometrium. The Doppler ultrasound was 
suggestive of morbidly adherent placenta.  
 
The couple was informed on the findings and 
risk of massive haemorrhage, requiring 
hysterectomy. Contemplating termination of 
pregnancy in view of extreme preterm prelabour 
rupture of membrane with recurrent bleeding 
from morbidly adherent placenta was the issue at 
that point.  
 
After two days in the ward, she developed 
another episode of sudden massive per vaginal 
bleeding associated with contractions. She was in 
a state of hypovolemic shock and was 
resuscitated with colloid and crystalloid before 
taken to the operation theatre for hysterotomy 
with possible hysterectomy.  
 
At laparotomy, the lower segment was not well 
formed with engorged vessels at the bladder base 
and uterine angles. Hysterotomy was performed 
delivering a 450 gm female fetus, with no 
respiratory effort, who expired after one hour of 
life. As partial separation of the placenta 
occurred, with the thought of conserving the 
uterus in mind, a short attempt of removal of the 
placenta was performed digitally but it failed. 
Some placental tissues bulk was extruded into 
the internal os of cervix posterior laterally and 
the placental bed started to bleed profusely. 
 
Due to a significant drop in blood pressure with 
massive bleeding, complicated with disseminated 
intravascular coagulopathy, conservative 
approach was not permitted in this patient. 
Therefore, a subtotal hysterectomy was 
performed as the patient was critically 
haemodynamically unstable. Intraoperatively, 
she lost six liters of blood which was corrected 
with seven units of blood, two units of platelet, 
four units of fresh frozen plasma, and six units of 
cryoprecipitate. Another course of DIVC regime 
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was given immediately postoperative. She 
recovered well after being observed in the 
intensive care unit for 36 hours. Histology report 
confirmed placenta accreta. 
 
Case report 2 
 
A 34-year-old, in her second pregnancy with one 
previous dilatation and curettage, was then at 22 
weeks gestation following spontaneous 
conception after three years history of 
unexplained subfertility, presented with per 
vaginal bleeding. This pregnancy dated at six 
weeks and her pregnancy progressed well until 
the day of admission. Following that, she had the 
spontaneous leaking liquor.  
 
Upon assessment, she was not pale with stable 
haemodynamic status. The uterus was smaller 
than dates with evidence of oligohydramnios and 
rupture of membranes was confirmed. Obstetric 
ultrasound confirmed anhydramnion, low lying 
placenta with evidence suggesting placenta 
accreta such as prominent lacunae sign and loss 
of plane between placental tissue and the 
myometrium. 
 
As the prognosis was poor, with possible lungs 
hypoplasia, and limbs deformity, she was given 
the option of termination of pregnancy, which 
she was keen on. Given the history of low lying 
placenta with suspected accreta, the best mode of 
termination of pregnancy was a crucial issue. 
The risk of procedure failure, bleeding, infection, 
needing surgical intervention, namely 
hysterectomy were highlighted during 
discussion.  
 
Fetocide with intracardiac potassium chloride 
injection followed by systemic intramuscular 
methotrexate was administered for one course. 
Two days following the procedure, she passed 
out placenta tissues and 300gm of fetus. She 
required curettage for the retained tissue but the 
completeness was not achieved due to the 
adherence  and was left in-situ. She was 
administered antibiotics and recovered well, and 
the serial serum beta hCG dropped to pre-
pregnancy level four weeks later.  
 
One year later, the couple wanted another 
pregnancy. As a result of successful preservation 
of the uterus from hysterectomy due to placenta 
accreta, the woman had a normal pregnancy 
currently at 28 weeks with no placenta praevia. 
 
 
 
 
 
 
 
 
 
Discussion 
 
As expected, morbidly adherence placenta is 
associated with major obstetric haemorrhage and 
increased maternal morbidity. Two illustrated 
cases revealed similar presentation with 
suspected morbidly adherent placenta at extreme 
prematurity with different approaches of 
management. Active intervention allays the 
possibility of hysterectomy, where fertility is of 
controversial concern.  
Fig 1: Macroscopic cross section of the uterus with gross 
extrusion of placental tissues into the myometrium and 
extending into the endocervical area. 
 
Fig 2: Sections show placental villi adhering to the 
underlying myometrium without an intervening layer of 
deciduas. The chorionic villi are also adhering to the 
cervical wall. 
Shafiee MN et al.Morbidly adherent placenta. 
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In the first case, the suspicion of placenta accreta 
arose when ultrasound scan revealed lacunae 
signs and loss of demarcation between placental 
tissue and myometrium at 21 weeks pregnancy 
when the visualization of the signs were more 
likely. Dilemma on the diagnostic capability is 
still a major issue especially at extremely early 
gestation because of the presence of other risk 
factors and stratification of the definite risk. A 
previous study reported cases of three previous 
Caesarean sections that had incomplete 
miscarriage at 10 weeks gestations, with heavy 
bleeding which was not responsive to bimanual 
compression, curettage and oxytocin infusion, 
requiring a hysterectomy (8). The pathologist 
reported it as placenta percreta.  
Issue regarding termination of pregnancy should 
be discussed earlier after adequate counseling to 
avoid consequences of massive haemorrhage 
needing hysterectomy and jeopardizing womens’ 
health.  This is ethically supported  by Clinical 
Opinion, American Journal of Obstetrics and 
Gynaecology, Dec 2009, whereby maternal 
condition or treatment of such a condition results 
in an increased risk to the woman’s health or life 
should she continue her pregnancy, or 
complications that threaten the woman’s health 
or life and salvage of the fetus is clinically 
hopeless- justifying termination of pregnancy 
(9). In addition to morbidly adherence placenta, 
both illustrated cases had early rupture of 
membrane where fetal outcome is theoretically 
very poor.  
To date, there is scarce evidence in the treatment 
of this condition during early pregnancy (7,8).  
Other concern would be the possible risk of 
bleeding even during the procedure in view of 
the low lying placenta. However, a study by 
Daisuke Nakayama et al (2007) found that there 
was no statistical difference in the mean 
intraoperative blood loss between medical and 
surgical termination of pregnancy in placenta 
praevia (10). 
More so, these cases having spontaneous leaking 
at extreme prematurity poses poor prognosis to 
the fetus, where termination of pregnancy is 
more justified, on top of the risk of maintaining 
pregnancy with possible accreta needing 
hysterectomy. Fetocide with injection of 
potassium chloride and subsequently systemic 
methotrexate for regression of decidual function 
could be the option, if only the life threatening 
condition concerning morbidly adherent placenta 
was highlighted in the earlier case. It was proven 
to be successful in the second case where uterus 
was well preserved. Methotrexate was essentially 
required to expedite the placental involution (1). 
By administering intra-cardiac injection of 
potassium chloride alone, the regression of 
placental function will be delayed to achieve 
avascular, non-viable product of conception, 
allaying risk of bleeding.  
 
Bilateral internal iliac artery ligation was 
considered in the first case, to reduce the 
bleeding but it was not practical as it would  
require more time when her life was at stake. 
Even, with initial intention of conserving the 
uterus with digital evacuation of the placental 
tissues or trimming of the placental bulk, it was 
never a realistic accurate approach at that 
situation of ‘adrenaline surge’. With the 
placental tissue encroached into the cervix and 
tightly adhered at the posterior lateral uterine 
wall, it was later discovered that the possibility 
of previous Caesarean section was complicated 
with extended downward uterine tear which is 
supported by earlier researchers (3).   
 
In conclusion, termination of pregnancy and 
systemic methotrexate would be an option in 
highly suspicious cases of morbidly adherence 
placenta at extreme prematurity to avoid massive 
obstetric haemorrhage and hysterectomy. 
However, proper evaluation and counseling is 
mandatory, and decision should be made on 
case-to-case basis. 
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